Lusay, Abbie L.
HRN: 23-82-57 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2023
CEFTRIAXONE 1G (VIAL)
10/08/2023
10/15/2023
IV
500 Mg
Every 24 Hours
PCAP-C; UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes